Open AccessJournal Article
Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array
1
TL;DR: Combined with the bioinformational method, the cDNA array is able to profile gene expression in different types of gliomas and may be a new method for studying molecular pathology of tumors.
read more
Abstract: BACKGROUND & OBJECTIVE There is great signification to classify the molecular pathogenesis of gliomas. Gene chip is able to profile the gene expression of tumors, which may become a new method for studying molecular pathology of tumors. The cDNA was used in order to detect the differences in gene expression profiles of different types of gliomas. METHODS cDNA probes tagged with 32P were converted from total RNA extracted from 4 samples of 3 different pathological types, including oligodendrogliomas, anaplastic astrocytomas and ependymomas, and one sample of normal human brain tissue as well, which were then hybridized to the Atlas array. After autoradiography, the gene expression profiles were analyzed with the special software and by the cluster analysis. RESULTS As compared to the normal brain tissue, the number of differential expressed genes in these tumor samples ranging from 11 to 118 was found. These 4 samples could be divided into 3 kinds of types when 107 differential expressed genes were selected to be as the cluster analysis index. This result was in accordance with the neuropathological diagnosis. CONCLUSION cDNA array is able to profile gene expression in different types of gliomas. Combined with the bioinformational method, we may further obtain useful information about molecular pathology of gliomas.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The Impact of Microarray Technology in Brain Cancer
M.G. Kounelakis,M. Zervakis,X. Kotsiakis +2 more
- 01 Jan 2007
TL;DR: This chapter attempts to reveal the important role of genomics in brain cancer by reviewing several genomic-based methods for brain cancer analysis and compared to traditional ones with an emphasis to DNA microarray technology that was recently introduced.
7